Finance

Beta
Lists
TRILC:IST
Turk Ilac Ve Serum Sanayi AS
TRY 2.46
0.00%
(0.00) 1D
Jun 2, 6:09:44 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for TRILC...
Mkt. cap
2.55B
Avg. vol.
143.52M
Volume
0.00
52-wk high
TRY 4.40
52-wk low
TRY 2.25
EPS
-TRY 0.05
Shares outstanding
1.04B
No. of employees
689
Mkt. cap
2.55B
Avg. vol.
143.52M
Volume
0.00
52-wk high
TRY 4.40
52-wk low
TRY 2.25
EPS
-TRY 0.05
Shares outstanding
1.04B
No. of employees
689
News stories
From sources across the web
About Turk Ilac Ve Serum Sanayi AS
CEO-
Employees689
Founded2010
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
838.00M
1.17B
1.85B
1.39B
Cost of goods sold
592.67M
777.88M
1.07B
1.04B
Cost of revenue
592.67M
777.88M
1.07B
1.04B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79.56M
135.28M
110.43M
120.97M
Operating expense
118.11M
88.56M
183.13M
28.24M
Total operating expenses
710.77M
866.44M
1.25B
1.07B
Operating income
127.23M
305.91M
594.60M
322.93M
Other non operating income
82.79M
141.77M
-141.16M
742.32M
EBT including unusual items
-203.49M
207.12M
-194.54M
319.32M
EBT excluding unusual items
-196.46M
207.12M
-158.93M
369.53M
Income tax expense
91.23M
88.11M
-66.57M
111.77M
Effective tax rate
-44.83%
42.54%
34.22%
35.00%
Other operating expenses
45.36M
-46.72M
65.64M
-92.73M
Net income
-294.72M
119.01M
-127.97M
207.56M
Net profit margin
-35.17%
10.15%
-6.93%
14.95%
Earnings per share
-
-
-
-
Interest and investment income
26.29M
35.77M
-
100.99K
Interest expense
-477.21M
-276.34M
-616.53M
-695.83M
Net interest expenses
-450.92M
-240.56M
-616.53M
-695.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
140.35M
323.94M
612.03M
355.44M
Gain or loss from assets sale
-
-
6.51M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more